Search research articles
Contact Us
Filters
Showing results (21-30 of 197) with videos related to
Page
of 20
Sort By:
The Journal of Biological Chemistry
|
December 2, 2015
Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease
Brian Spencer, Rewati Potkar, Jeff Metcalf, et al.
Neuroreport
|
February 9, 2012
Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy
Edward Rockenstein, Kiren Ubhi, Chandra Inglis, et al.
Brain Research
|
February 13, 2025
Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 102-110]
Andrew O Koob, Gideon M Shaked, Andreas Bender, et al.
Neuroreport
|
March 13, 2010
Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy
Kiren Ubhi, Edward Rockenstein, Michael Mante, et al.
Experimental Neurology
|
November 26, 2009
Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
Corinne G Jolivalt, Rosemarie Hurford, Corinne A Lee, et al.
Journal of Neuroinflammation
|
September 20, 2012
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice
Markus Britschgi, Yoshiko Takeda-Uchimura, Edward Rockenstein, et al.
Brain Research
|
December 3, 2014
Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease
Andrew O Koob, Gideon M Shaked, Andreas Bender, et al.
The Journal of Biological Chemistry
|
March 18, 2004
Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease
Makoto Hashimoto, Pazit Bar-On, Gilbert Ho, et al.
Journal of Neuroscience Research
|
July 12, 2002
Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters
Edward Rockenstein, Margaret Mallory, Makoto Hashimoto, et al.
Journal of Alzheimer'S Disease : JAD
|
March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease
Daniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 197) with videos related to
Sort By:
Page
of 20
The Journal of Biological Chemistry
|
December 2, 2015
Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease
Brian Spencer, Rewati Potkar, Jeff Metcalf, et al.
Neuroreport
|
February 9, 2012
Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy
Edward Rockenstein, Kiren Ubhi, Chandra Inglis, et al.
Brain Research
|
February 13, 2025
Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 102-110]
Andrew O Koob, Gideon M Shaked, Andreas Bender, et al.
Neuroreport
|
March 13, 2010
Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy
Kiren Ubhi, Edward Rockenstein, Michael Mante, et al.
Experimental Neurology
|
November 26, 2009
Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
Corinne G Jolivalt, Rosemarie Hurford, Corinne A Lee, et al.
Journal of Neuroinflammation
|
September 20, 2012
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice
Markus Britschgi, Yoshiko Takeda-Uchimura, Edward Rockenstein, et al.
Brain Research
|
December 3, 2014
Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease
Andrew O Koob, Gideon M Shaked, Andreas Bender, et al.
The Journal of Biological Chemistry
|
March 18, 2004
Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease
Makoto Hashimoto, Pazit Bar-On, Gilbert Ho, et al.
Journal of Neuroscience Research
|
July 12, 2002
Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters
Edward Rockenstein, Margaret Mallory, Makoto Hashimoto, et al.
Journal of Alzheimer'S Disease : JAD
|
March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease
Daniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.
Page
of 20